IFNG and parasitic infectious disease: Additionally, in in vivo parasite infection models, IL-27 inhibits IFN-γ production and attenuates disease pathology associated with Toxoplasma gondii, Trypanosoma cruzi, Plasmodium berghei, Leishmania donovani, and malaria [46–49].